✦ LIBER ✦

Differential expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA in periodontal diseases

✍ Scribed by N. Bostancı; T. İlgenli; G. Emingil; B. Afacan; B. Han; H. Töz; A. Berdeli; G. Atilla; I. J. McKay; F. J. Hughes; G. N. Belibasakis

Book ID: 111261111
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 560 KB
Volume: 42
Category: Article
ISSN: 0022-3484
DOI: 10.1111/j.1600-0765.2006.00946.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Soluble Receptor Activator of Nuclear Fa

Soluble Receptor Activator of Nuclear Factor-κB Ligand (sRANKL)/Osteoprotegerin Balance in Ageing and Age-Associated Diseases

✍ Lia Pulsatelli; Paolo Dolzani; Tania Silvestri; Paolo Caraceni; Andrea Facchini; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 112 KB

Receptor activator of nuclear factor κB

Receptor activator of nuclear factor κB ligand and osteoprotegerin in men with thyroid cancer

✍ P. Mikosch; I. Igerc; S. Kudlacek; W. Woloszczuk; H. J. Gallowitsch; E. Kresnik; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Role of receptor activator of nuclear fa

Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology

✍ Lorenz C. Hofbauer; Armin E. Heufelder 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 119 KB

In vitro expression of receptor activato

In vitro expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin in cultured equine articular cells

✍ Byron, Christopher R.; Barger, Anne M.; Stewart, Allison A.; Pondenis, Holly C.; 📂 Article 📅 2010 🏛 American Veterinary Medicine Association 🌐 English ⚖ 593 KB

Expression of receptor activator of nucl

Expression of receptor activator of nuclear factor -κB ligand, receptor activator of nuclear factor -κB, and osteoprotegerin, following low-level laser treatment on deproteinized bovine bone graft in rats

✍ Yong-Deok Kim; Won-Wook Song; Seong-Sik Kim; Gyu-Cheon Kim; Dae-Seok Hwang; Sang 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 574 KB

Plasma levels of receptor activator of n

Plasma levels of receptor activator of nuclear factor-κB ligand and osteoprotegerin in patients with neuroblastoma

✍ Donatella Granchi; Alberto Garaventa; Ilaria Amato; Paolo Paolucci; Nicola Baldi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 141 KB

## Abstract Earlier reports showed that the balance between receptor activator of nuclear factor‐κB ligand (RANKL) and its decoy‐receptor osteoprotegerin (OPG) plays an important role in the pathogenesis of metastatic osteolysis induced by neuroblastoma cells. In this study, we investigated whether